Outset Medical
Financials
Estimates*
| USD | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 49.9m | 103m | 115m | 130m | 110m | 126m | 149m |
| % growth | 231 % | 105 % | 12 % | 13 % | (15 %) | 14 % | 18 % |
| EBITDA | (117m) | (130m) | (158m) | (154m) | (76.7m) | (53.3m) | (44.5m) |
| % EBITDA margin | (235 %) | (127 %) | (137 %) | (118 %) | (70 %) | (42 %) | (30 %) |
| Profit | (121m) | (132m) | (163m) | (173m) | (123m) | (94.3m) | (82.5m) |
| % profit margin | (243 %) | (129 %) | (141 %) | (133 %) | (112 %) | (75 %) | (55 %) |
| EV / revenue | 43.1x | 18.1x | 9.2x | 1.5x | -1.1x | -1.2x | -1.1x |
| EV / EBITDA | -18.3x | -14.3x | -6.7x | -1.3x | 1.6x | 2.9x | 3.7x |
| R&D budget | 28.9m | 36.7m | 48.9m | 57.3m | - | - | - |
| R&D % of revenue | 58 % | 36 % | 42 % | 44 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $4.5m | Early VC | |
$51.0m | Late VC | ||
$45.0m | Debt | ||
$76.5m | Series C | ||
| N/A | $4.3m | Debt | |
$132m | Series D | ||
* | $125m | Series E | |
| N/A | $241m | IPO | |
* | N/A | $150m | Post IPO Equity |
* | $300m | Post IPO Debt | |
* | $212k | Post IPO Equity | |
| Total Funding | CAD530m | ||
Recent News about Outset Medical
EditOutset Medical operates in the healthcare sector, specifically focusing on dialysis treatment. The company offers a comprehensive program that includes educational modules and hands-on training for dialysis professionals. Their product, Tablo, is designed to streamline dialysis workflows, from charting to billing, by integrating with electronic medical record (EMR) platforms. This integration allows for efficient and reliable management of patient data, with real-time updates and alerts on treatment progress.
In addition to this, Outset Medical offers a Vascular Access Program to help establish staff experience in cannulation and vascular access management, crucial for setting up dialysis services. The company also provides a Bridge Program for facilities transitioning from outsourced dialysis providers to owning their own dialysis service line. This program fills staffing and expertise gaps, with Outset dialysis nurses joining the staff full-time for a period of 4-13 weeks to provide support and training.
Outset Medical's business model is geared towards hospitals and health systems looking to enhance their services by providing comprehensive care to dialysis patients. This includes care in hospital settings, outpatient clinics, and patients’ homes. The company's revenue comes from the sale of their Tablo system, as well as the various training and support programs they offer.
Keywords: Dialysis treatment, Healthcare, Tablo, EMR integration, Vascular Access Program, Bridge Program, Comprehensive care, Hospital settings, Outpatient clinics, Home care.